nodes	percent_of_prediction	percent_of_DWPC	metapath
Acetylcysteine—CHUK—Sulfasalazine—ankylosing spondylitis	0.339	0.378	CbGbCtD
Acetylcysteine—IKBKB—Sulfasalazine—ankylosing spondylitis	0.245	0.273	CbGbCtD
Acetylcysteine—SLC7A11—Sulfasalazine—ankylosing spondylitis	0.245	0.273	CbGbCtD
Acetylcysteine—SLCO1B1—Sulfasalazine—ankylosing spondylitis	0.0405	0.0451	CbGbCtD
Acetylcysteine—SLCO1B1—Methotrexate—ankylosing spondylitis	0.0162	0.0181	CbGbCtD
Acetylcysteine—SLC22A6—Methotrexate—ankylosing spondylitis	0.0104	0.0116	CbGbCtD
Acetylcysteine—Erythema facial—Prednisolone—ankylosing spondylitis	0.0031	0.0739	CcSEcCtD
Acetylcysteine—Erythema facial—Methylprednisolone—ankylosing spondylitis	0.00285	0.0678	CcSEcCtD
Acetylcysteine—Erythema facial—Dexamethasone—ankylosing spondylitis	0.00259	0.0617	CcSEcCtD
Acetylcysteine—Erythema facial—Betamethasone—ankylosing spondylitis	0.00259	0.0617	CcSEcCtD
Acetylcysteine—Erythema facial—Prednisone—ankylosing spondylitis	0.00225	0.0537	CcSEcCtD
Acetylcysteine—CHUK—IL1-mediated signaling events—IL1R2—ankylosing spondylitis	0.00184	0.0318	CbGpPWpGaD
Acetylcysteine—CHUK—NOD1/2 Signaling Pathway—CARD9—ankylosing spondylitis	0.00172	0.0297	CbGpPWpGaD
Acetylcysteine—IKBKB—IL1-mediated signaling events—IL1R2—ankylosing spondylitis	0.00167	0.0288	CbGpPWpGaD
Acetylcysteine—CHUK—Interleukin-1 signaling—IL1R2—ankylosing spondylitis	0.00162	0.0279	CbGpPWpGaD
Acetylcysteine—IKBKB—NOD1/2 Signaling Pathway—CARD9—ankylosing spondylitis	0.00156	0.0269	CbGpPWpGaD
Acetylcysteine—IKBKB—Interleukin-1 signaling—IL1R2—ankylosing spondylitis	0.00147	0.0253	CbGpPWpGaD
Acetylcysteine—CHUK—NOD pathway—CARD9—ankylosing spondylitis	0.00138	0.0237	CbGpPWpGaD
Acetylcysteine—IKBKB—NOD pathway—CARD9—ankylosing spondylitis	0.00125	0.0215	CbGpPWpGaD
Acetylcysteine—CHUK—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CARD9—ankylosing spondylitis	0.00117	0.0203	CbGpPWpGaD
Acetylcysteine—IKBKB—Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways—CARD9—ankylosing spondylitis	0.00107	0.0184	CbGpPWpGaD
Acetylcysteine—IKBKB—IL17 signaling pathway—IL17A—ankylosing spondylitis	0.000897	0.0155	CbGpPWpGaD
Acetylcysteine—CHUK—IL1-mediated signaling events—IL1RN—ankylosing spondylitis	0.000872	0.015	CbGpPWpGaD
Acetylcysteine—CHUK—TNF receptor signaling pathway —TNFRSF1B—ankylosing spondylitis	0.000809	0.014	CbGpPWpGaD
Acetylcysteine—IKBKB—IL1-mediated signaling events—IL1RN—ankylosing spondylitis	0.000791	0.0136	CbGpPWpGaD
Acetylcysteine—CHUK—Interleukin-1 signaling—IL1RN—ankylosing spondylitis	0.000766	0.0132	CbGpPWpGaD
Acetylcysteine—IKBKB—Apoptosis Modulation and Signaling—IL1R2—ankylosing spondylitis	0.000761	0.0131	CbGpPWpGaD
Acetylcysteine—IKBKB—TNF receptor signaling pathway —TNFRSF1B—ankylosing spondylitis	0.000734	0.0127	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by Interleukins—IL1R2—ankylosing spondylitis	0.000732	0.0126	CbGpPWpGaD
Acetylcysteine—IKBKB—Interleukin-1 signaling—IL1RN—ankylosing spondylitis	0.000695	0.012	CbGpPWpGaD
Acetylcysteine—CHUK—IKK complex recruitment mediated by RIP1—TLR4—ankylosing spondylitis	0.000665	0.0115	CbGpPWpGaD
Acetylcysteine—CHUK—Endogenous TLR signaling—TLR4—ankylosing spondylitis	0.000665	0.0115	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling by Interleukins—IL1R2—ankylosing spondylitis	0.000663	0.0114	CbGpPWpGaD
Acetylcysteine—SLC7A11—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000652	0.0112	CbGpPWpGaD
Acetylcysteine—CHUK—IL1-mediated signaling events—IL1A—ankylosing spondylitis	0.000628	0.0108	CbGpPWpGaD
Acetylcysteine—IKBKB—Endogenous TLR signaling—TLR4—ankylosing spondylitis	0.000603	0.0104	CbGpPWpGaD
Acetylcysteine—IKBKB—IKK complex recruitment mediated by RIP1—TLR4—ankylosing spondylitis	0.000603	0.0104	CbGpPWpGaD
Acetylcysteine—IKBKB—IL1-mediated signaling events—IL1A—ankylosing spondylitis	0.000569	0.00982	CbGpPWpGaD
Acetylcysteine—GRIN1—SIDS Susceptibility Pathways—RUNX3—ankylosing spondylitis	0.000552	0.00953	CbGpPWpGaD
Acetylcysteine—CHUK—Interleukin-1 signaling—IL1A—ankylosing spondylitis	0.000551	0.00951	CbGpPWpGaD
Acetylcysteine—Wheezing—Triamcinolone—ankylosing spondylitis	0.000506	0.0121	CcSEcCtD
Acetylcysteine—IKBKB—Interleukin-1 signaling—IL1A—ankylosing spondylitis	0.0005	0.00862	CbGpPWpGaD
Acetylcysteine—CHUK—Apoptosis—TNFRSF1B—ankylosing spondylitis	0.0005	0.00862	CbGpPWpGaD
Acetylcysteine—CHUK—Structural Pathway of Interleukin 1 (IL-1)—IL1A—ankylosing spondylitis	0.000485	0.00836	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—IL1R2—ankylosing spondylitis	0.000466	0.00804	CbGpPWpGaD
Acetylcysteine—CHUK—TNF alpha Signaling Pathway—TNFRSF1B—ankylosing spondylitis	0.000465	0.00802	CbGpPWpGaD
Acetylcysteine—CHUK—Leptin signaling pathway—IL1RN—ankylosing spondylitis	0.000463	0.00799	CbGpPWpGaD
Acetylcysteine—IKBKB—Apoptosis—TNFRSF1B—ankylosing spondylitis	0.000453	0.00782	CbGpPWpGaD
Acetylcysteine—CHUK—BCR signaling pathway—CD79A—ankylosing spondylitis	0.000445	0.00768	CbGpPWpGaD
Acetylcysteine—IKBKB—Structural Pathway of Interleukin 1 (IL-1)—IL1A—ankylosing spondylitis	0.000439	0.00758	CbGpPWpGaD
Acetylcysteine—CHUK—IL-1 signaling pathway—IL1A—ankylosing spondylitis	0.000427	0.00737	CbGpPWpGaD
Acetylcysteine—IKBKB—Apoptosis Modulation and Signaling—TNFRSF1B—ankylosing spondylitis	0.000425	0.00733	CbGpPWpGaD
Acetylcysteine—Anaphylactoid reaction—Prednisolone—ankylosing spondylitis	0.000425	0.0101	CcSEcCtD
Acetylcysteine—CHUK—TCR Signaling Pathway—IL17A—ankylosing spondylitis	0.000422	0.00727	CbGpPWpGaD
Acetylcysteine—IKBKB—TNF alpha Signaling Pathway—TNFRSF1B—ankylosing spondylitis	0.000421	0.00727	CbGpPWpGaD
Acetylcysteine—SLC7A11—Dexamethasone—Methylprednisolone—ankylosing spondylitis	0.000421	0.105	CbGdCrCtD
Acetylcysteine—SLC7A11—Betamethasone—Methylprednisolone—ankylosing spondylitis	0.000421	0.105	CbGdCrCtD
Acetylcysteine—IKBKB—Leptin signaling pathway—IL1RN—ankylosing spondylitis	0.00042	0.00725	CbGpPWpGaD
Acetylcysteine—SLC7A11—Betamethasone—Dexamethasone—ankylosing spondylitis	0.000414	0.104	CbGdCrCtD
Acetylcysteine—SLC7A11—Dexamethasone—Betamethasone—ankylosing spondylitis	0.000414	0.104	CbGdCrCtD
Acetylcysteine—SLC7A11—Betamethasone—Triamcinolone—ankylosing spondylitis	0.000405	0.101	CbGdCrCtD
Acetylcysteine—SLC7A11—Dexamethasone—Triamcinolone—ankylosing spondylitis	0.000405	0.101	CbGdCrCtD
Acetylcysteine—IKBKB—BCR signaling pathway—CD79A—ankylosing spondylitis	0.000404	0.00696	CbGpPWpGaD
Acetylcysteine—Anaphylactoid reaction—Triamcinolone—ankylosing spondylitis	0.000391	0.00931	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Methylprednisolone—ankylosing spondylitis	0.00039	0.00929	CcSEcCtD
Acetylcysteine—IKBKB—IL-1 signaling pathway—IL1A—ankylosing spondylitis	0.000388	0.00668	CbGpPWpGaD
Acetylcysteine—CHUK—TCR signaling in naïve CD8+ T cells—HLA-A—ankylosing spondylitis	0.000386	0.00665	CbGpPWpGaD
Acetylcysteine—SLC7A11—Betamethasone—Prednisone—ankylosing spondylitis	0.000384	0.0961	CbGdCrCtD
Acetylcysteine—SLC7A11—Dexamethasone—Prednisone—ankylosing spondylitis	0.000384	0.0961	CbGdCrCtD
Acetylcysteine—IKBKB—TCR Signaling Pathway—IL17A—ankylosing spondylitis	0.000382	0.00659	CbGpPWpGaD
Acetylcysteine—GRIN1—SIDS Susceptibility Pathways—IL1RN—ankylosing spondylitis	0.000381	0.00658	CbGpPWpGaD
Acetylcysteine—Eye pain—Dexamethasone—ankylosing spondylitis	0.00038	0.00905	CcSEcCtD
Acetylcysteine—Eye pain—Betamethasone—ankylosing spondylitis	0.00038	0.00905	CcSEcCtD
Acetylcysteine—CHUK—p75(NTR)-mediated signaling—MMP3—ankylosing spondylitis	0.000377	0.0065	CbGpPWpGaD
Acetylcysteine—SLC7A11—Betamethasone—Prednisolone—ankylosing spondylitis	0.000375	0.0938	CbGdCrCtD
Acetylcysteine—SLC7A11—Dexamethasone—Prednisolone—ankylosing spondylitis	0.000375	0.0938	CbGdCrCtD
Acetylcysteine—CHUK—Toll-like Receptor Signaling Pathway—IL12B—ankylosing spondylitis	0.000355	0.00612	CbGpPWpGaD
Acetylcysteine—Anaphylactoid reaction—Betamethasone—ankylosing spondylitis	0.000355	0.00845	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Dexamethasone—ankylosing spondylitis	0.000355	0.00845	CcSEcCtD
Acetylcysteine—IKBKB—TCR signaling in naïve CD8+ T cells—HLA-A—ankylosing spondylitis	0.00035	0.00603	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by Interleukins—IL1RN—ankylosing spondylitis	0.000346	0.00597	CbGpPWpGaD
Acetylcysteine—GRIN1—Spinal Cord Injury—IL1A—ankylosing spondylitis	0.000343	0.00592	CbGpPWpGaD
Acetylcysteine—IKBKB—p75(NTR)-mediated signaling—MMP3—ankylosing spondylitis	0.000342	0.0059	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—IL1R2—ankylosing spondylitis	0.000341	0.00589	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Receptor Signaling Pathway—CD79A—ankylosing spondylitis	0.000331	0.00571	CbGpPWpGaD
Acetylcysteine—Asthma—Triamcinolone—ankylosing spondylitis	0.000327	0.00779	CcSEcCtD
Acetylcysteine—CHUK—Canonical NF-kappaB pathway—TNF—ankylosing spondylitis	0.000325	0.0056	CbGpPWpGaD
Acetylcysteine—CHUK—EBV LMP1 signaling—TNF—ankylosing spondylitis	0.000325	0.0056	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll-like Receptor Signaling Pathway—IL12B—ankylosing spondylitis	0.000322	0.00555	CbGpPWpGaD
Acetylcysteine—Bronchospasm—Methylprednisolone—ankylosing spondylitis	0.000321	0.00764	CcSEcCtD
Acetylcysteine—IKBKB—Signaling by Interleukins—IL1RN—ankylosing spondylitis	0.000314	0.00541	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—IL1R2—ankylosing spondylitis	0.00031	0.00534	CbGpPWpGaD
Acetylcysteine—IKBKB—Type II diabetes mellitus—TNF—ankylosing spondylitis	0.000305	0.00526	CbGpPWpGaD
Acetylcysteine—ACY1—Metabolism—B3GNT2—ankylosing spondylitis	0.000305	0.00526	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.000303	0.00523	CbGpPWpGaD
Acetylcysteine—IKBKB—B Cell Receptor Signaling Pathway—CD79A—ankylosing spondylitis	0.0003	0.00518	CbGpPWpGaD
Acetylcysteine—IKBKB—Canonical NF-kappaB pathway—TNF—ankylosing spondylitis	0.000295	0.00508	CbGpPWpGaD
Acetylcysteine—IKBKB—EBV LMP1 signaling—TNF—ankylosing spondylitis	0.000295	0.00508	CbGpPWpGaD
Acetylcysteine—Face oedema—Prednisone—ankylosing spondylitis	0.000289	0.00687	CcSEcCtD
Acetylcysteine—CHUK—TCR Signaling Pathway—IL1A—ankylosing spondylitis	0.000288	0.00497	CbGpPWpGaD
Acetylcysteine—SLC22A6—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00028	0.00483	CbGpPWpGaD
Acetylcysteine—Sweating—Methylprednisolone—ankylosing spondylitis	0.000279	0.00664	CcSEcCtD
Acetylcysteine—CHUK—Regulation of toll-like receptor signaling pathway—IL12B—ankylosing spondylitis	0.000277	0.00477	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—KIR3DL1—ankylosing spondylitis	0.000275	0.00475	CbGpPWpGaD
Acetylcysteine—GRIN1—Spinal Cord Injury—TLR4—ankylosing spondylitis	0.000275	0.00474	CbGpPWpGaD
Acetylcysteine—GRIN1—SIDS Susceptibility Pathways—IL1A—ankylosing spondylitis	0.000274	0.00473	CbGpPWpGaD
Acetylcysteine—GRIN1—SIDS Susceptibility Pathways—IL10—ankylosing spondylitis	0.000273	0.00471	CbGpPWpGaD
Acetylcysteine—CHUK—DAP12 interactions—HLA-C—ankylosing spondylitis	0.000268	0.00463	CbGpPWpGaD
Acetylcysteine—IKBKB—TCR Signaling Pathway—IL1A—ankylosing spondylitis	0.000261	0.00451	CbGpPWpGaD
Acetylcysteine—Pharyngitis—Triamcinolone—ankylosing spondylitis	0.00026	0.00619	CcSEcCtD
Acetylcysteine—Anaphylactoid reaction—Methotrexate—ankylosing spondylitis	0.000258	0.00615	CcSEcCtD
Acetylcysteine—SLCO1B1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000255	0.0044	CbGpPWpGaD
Acetylcysteine—IKBKB—Regulation of toll-like receptor signaling pathway—IL12B—ankylosing spondylitis	0.000251	0.00433	CbGpPWpGaD
Acetylcysteine—GRIN2D—Alzheimers Disease—TNF—ankylosing spondylitis	0.00025	0.00431	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling by Interleukins—IL1A—ankylosing spondylitis	0.000249	0.0043	CbGpPWpGaD
Acetylcysteine—Erythema—Prednisolone—ankylosing spondylitis	0.000248	0.0059	CcSEcCtD
Acetylcysteine—CHUK—HIV-1 Nef: Negative effector of Fas and TNF-alpha—TNF—ankylosing spondylitis	0.000243	0.0042	CbGpPWpGaD
Acetylcysteine—Cardiac disorder—Methylprednisolone—ankylosing spondylitis	0.000242	0.00577	CcSEcCtD
Acetylcysteine—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.000237	0.00564	CcSEcCtD
Acetylcysteine—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.000236	0.00562	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Methylprednisolone—ankylosing spondylitis	0.000235	0.0056	CcSEcCtD
Acetylcysteine—Erythema—Triamcinolone—ankylosing spondylitis	0.000228	0.00543	CcSEcCtD
Acetylcysteine—Erythema—Methylprednisolone—ankylosing spondylitis	0.000227	0.00541	CcSEcCtD
Acetylcysteine—Angioedema—Prednisolone—ankylosing spondylitis	0.000226	0.00539	CcSEcCtD
Acetylcysteine—IKBKB—Signaling by Interleukins—IL1A—ankylosing spondylitis	0.000226	0.0039	CbGpPWpGaD
Acetylcysteine—CHUK—MyD88:Mal cascade initiated on plasma membrane—TLR4—ankylosing spondylitis	0.000223	0.00385	CbGpPWpGaD
Acetylcysteine—Syncope—Prednisolone—ankylosing spondylitis	0.000222	0.00529	CcSEcCtD
Acetylcysteine—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.000218	0.00519	CcSEcCtD
Acetylcysteine—Asthma—Methotrexate—ankylosing spondylitis	0.000216	0.00514	CcSEcCtD
Acetylcysteine—Angiopathy—Betamethasone—ankylosing spondylitis	0.000215	0.00513	CcSEcCtD
Acetylcysteine—Angiopathy—Dexamethasone—ankylosing spondylitis	0.000215	0.00513	CcSEcCtD
Acetylcysteine—CHUK—MyD88-independent cascade—TLR4—ankylosing spondylitis	0.000214	0.00369	CbGpPWpGaD
Acetylcysteine—CHUK—Toll-like Receptor Signaling Pathway—TLR4—ankylosing spondylitis	0.000209	0.0036	CbGpPWpGaD
Acetylcysteine—Angioedema—Triamcinolone—ankylosing spondylitis	0.000208	0.00496	CcSEcCtD
Acetylcysteine—Angioedema—Methylprednisolone—ankylosing spondylitis	0.000208	0.00495	CcSEcCtD
Acetylcysteine—Erythema—Betamethasone—ankylosing spondylitis	0.000207	0.00492	CcSEcCtD
Acetylcysteine—Erythema—Dexamethasone—ankylosing spondylitis	0.000207	0.00492	CcSEcCtD
Acetylcysteine—GRIN2A—Alzheimers Disease—TNF—ankylosing spondylitis	0.000205	0.00354	CbGpPWpGaD
Acetylcysteine—Syncope—Triamcinolone—ankylosing spondylitis	0.000204	0.00487	CcSEcCtD
Acetylcysteine—Syncope—Methylprednisolone—ankylosing spondylitis	0.000204	0.00485	CcSEcCtD
Acetylcysteine—IKBKB—MyD88:Mal cascade initiated on plasma membrane—TLR4—ankylosing spondylitis	0.000202	0.00349	CbGpPWpGaD
Acetylcysteine—Oedema—Prednisolone—ankylosing spondylitis	0.000202	0.00481	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Prednisolone—ankylosing spondylitis	0.000202	0.00481	CcSEcCtD
Acetylcysteine—CHUK—TWEAK Signaling Pathway—TNF—ankylosing spondylitis	0.000201	0.00346	CbGpPWpGaD
Acetylcysteine—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.0002	0.00477	CcSEcCtD
Acetylcysteine—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.0002	0.00476	CcSEcCtD
Acetylcysteine—Shock—Prednisolone—ankylosing spondylitis	0.000199	0.00474	CcSEcCtD
Acetylcysteine—Cough—Triamcinolone—ankylosing spondylitis	0.000199	0.00473	CcSEcCtD
Acetylcysteine—Tachycardia—Prednisolone—ankylosing spondylitis	0.000197	0.0047	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000195	0.00465	CcSEcCtD
Acetylcysteine—IKBKB—MyD88-independent cascade—TLR4—ankylosing spondylitis	0.000194	0.00335	CbGpPWpGaD
Acetylcysteine—CHUK—Activated TLR4 signalling—TLR4—ankylosing spondylitis	0.000193	0.00332	CbGpPWpGaD
Acetylcysteine—Drowsiness—Methotrexate—ankylosing spondylitis	0.000192	0.00458	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.000192	0.00458	CcSEcCtD
Acetylcysteine—Flushing—Prednisone—ankylosing spondylitis	0.000192	0.00457	CcSEcCtD
Acetylcysteine—IKBKB—Toll-like Receptor Signaling Pathway—TLR4—ankylosing spondylitis	0.000189	0.00327	CbGpPWpGaD
Acetylcysteine—CHUK—B Cell Activation—CD79A—ankylosing spondylitis	0.000189	0.00327	CbGpPWpGaD
Acetylcysteine—Angioedema—Betamethasone—ankylosing spondylitis	0.000189	0.0045	CcSEcCtD
Acetylcysteine—Angioedema—Dexamethasone—ankylosing spondylitis	0.000189	0.0045	CcSEcCtD
Acetylcysteine—Stomatitis—Methotrexate—ankylosing spondylitis	0.000188	0.00447	CcSEcCtD
Acetylcysteine—Angiopathy—Prednisone—ankylosing spondylitis	0.000188	0.00447	CcSEcCtD
Acetylcysteine—Immune system disorder—Prednisone—ankylosing spondylitis	0.000187	0.00445	CcSEcCtD
Acetylcysteine—CHUK—TNF receptor signaling pathway —TNF—ankylosing spondylitis	0.000187	0.00322	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—HLA-C—ankylosing spondylitis	0.000186	0.00321	CbGpPWpGaD
Acetylcysteine—Oedema—Triamcinolone—ankylosing spondylitis	0.000186	0.00443	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Triamcinolone—ankylosing spondylitis	0.000186	0.00443	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Methylprednisolone—ankylosing spondylitis	0.000185	0.00442	CcSEcCtD
Acetylcysteine—Syncope—Dexamethasone—ankylosing spondylitis	0.000185	0.00441	CcSEcCtD
Acetylcysteine—Syncope—Betamethasone—ankylosing spondylitis	0.000185	0.00441	CcSEcCtD
Acetylcysteine—Sweating—Methotrexate—ankylosing spondylitis	0.000185	0.0044	CcSEcCtD
Acetylcysteine—CHUK—Immune System—KIR3DL1—ankylosing spondylitis	0.000184	0.00317	CbGpPWpGaD
Acetylcysteine—Shock—Triamcinolone—ankylosing spondylitis	0.000183	0.00436	CcSEcCtD
Acetylcysteine—Shock—Methylprednisolone—ankylosing spondylitis	0.000182	0.00435	CcSEcCtD
Acetylcysteine—IKBKB—TWEAK Signaling Pathway—TNF—ankylosing spondylitis	0.000182	0.00314	CbGpPWpGaD
Acetylcysteine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000182	0.00433	CcSEcCtD
Acetylcysteine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000182	0.00433	CcSEcCtD
Acetylcysteine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000181	0.00432	CcSEcCtD
Acetylcysteine—CHUK—Toll Like Receptor 4 (TLR4) Cascade—TLR4—ankylosing spondylitis	0.000181	0.00312	CbGpPWpGaD
Acetylcysteine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000181	0.00431	CcSEcCtD
Acetylcysteine—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00018	0.00429	CcSEcCtD
Acetylcysteine—Erythema—Prednisone—ankylosing spondylitis	0.00018	0.00429	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00018	0.00428	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000179	0.00427	CcSEcCtD
Acetylcysteine—GRIN1—Alzheimers Disease—TNF—ankylosing spondylitis	0.000179	0.00309	CbGpPWpGaD
Acetylcysteine—GSS—Metabolism—B3GNT2—ankylosing spondylitis	0.000175	0.00302	CbGpPWpGaD
Acetylcysteine—IKBKB—Activated TLR4 signalling—TLR4—ankylosing spondylitis	0.000175	0.00301	CbGpPWpGaD
Acetylcysteine—GRIN2B—Alzheimers Disease—TNF—ankylosing spondylitis	0.000174	0.00301	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.000174	0.00301	CbGpPWpGaD
Acetylcysteine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000173	0.00413	CcSEcCtD
Acetylcysteine—IKBKB—B Cell Activation—CD79A—ankylosing spondylitis	0.000172	0.00296	CbGpPWpGaD
Acetylcysteine—Pharyngitis—Methotrexate—ankylosing spondylitis	0.000171	0.00408	CcSEcCtD
Acetylcysteine—IKBKB—TNF receptor signaling pathway —TNF—ankylosing spondylitis	0.000169	0.00292	CbGpPWpGaD
Acetylcysteine—Anaphylactic shock—Betamethasone—ankylosing spondylitis	0.000169	0.00402	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Dexamethasone—ankylosing spondylitis	0.000169	0.00402	CcSEcCtD
Acetylcysteine—Oedema—Dexamethasone—ankylosing spondylitis	0.000169	0.00402	CcSEcCtD
Acetylcysteine—Oedema—Betamethasone—ankylosing spondylitis	0.000169	0.00402	CcSEcCtD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—HLA-C—ankylosing spondylitis	0.000169	0.00291	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—KIR3DL1—ankylosing spondylitis	0.000167	0.00288	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—CARD9—ankylosing spondylitis	0.000166	0.00286	CbGpPWpGaD
Acetylcysteine—Shock—Betamethasone—ankylosing spondylitis	0.000166	0.00395	CcSEcCtD
Acetylcysteine—Shock—Dexamethasone—ankylosing spondylitis	0.000166	0.00395	CcSEcCtD
Acetylcysteine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000166	0.00395	CcSEcCtD
Acetylcysteine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000165	0.00392	CcSEcCtD
Acetylcysteine—Tachycardia—Betamethasone—ankylosing spondylitis	0.000165	0.00392	CcSEcCtD
Acetylcysteine—Angioedema—Prednisone—ankylosing spondylitis	0.000164	0.00392	CcSEcCtD
Acetylcysteine—IKBKB—Toll Like Receptor 4 (TLR4) Cascade—TLR4—ankylosing spondylitis	0.000164	0.00283	CbGpPWpGaD
Acetylcysteine—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.000164	0.0039	CcSEcCtD
Acetylcysteine—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.000163	0.00389	CcSEcCtD
Acetylcysteine—CHUK—Regulation of toll-like receptor signaling pathway—TLR4—ankylosing spondylitis	0.000163	0.00281	CbGpPWpGaD
Acetylcysteine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000163	0.00388	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000163	0.00388	CcSEcCtD
Acetylcysteine—CHUK—Cardiac Hypertrophic Response—TNF—ankylosing spondylitis	0.000162	0.00279	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—IL1RN—ankylosing spondylitis	0.000162	0.00279	CbGpPWpGaD
Acetylcysteine—Syncope—Prednisone—ankylosing spondylitis	0.000161	0.00384	CcSEcCtD
Acetylcysteine—CHUK—Toll-Like Receptors Cascades—TLR4—ankylosing spondylitis	0.000161	0.00278	CbGpPWpGaD
Acetylcysteine—Urticaria—Prednisolone—ankylosing spondylitis	0.000161	0.00383	CcSEcCtD
Acetylcysteine—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00016	0.00382	CcSEcCtD
Acetylcysteine—CHUK—DAP12 interactions—HLA-B—ankylosing spondylitis	0.000159	0.00274	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—IL1A—ankylosing spondylitis	0.000159	0.00274	CbGpPWpGaD
Acetylcysteine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000158	0.00377	CcSEcCtD
Acetylcysteine—IKBKB—Adaptive Immune System—ERAP1—ankylosing spondylitis	0.000158	0.00273	CbGpPWpGaD
Acetylcysteine—Hypotension—Dexamethasone—ankylosing spondylitis	0.000158	0.00375	CcSEcCtD
Acetylcysteine—Hypotension—Betamethasone—ankylosing spondylitis	0.000158	0.00375	CcSEcCtD
Acetylcysteine—Angiopathy—Methotrexate—ankylosing spondylitis	0.000157	0.00373	CcSEcCtD
Acetylcysteine—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000156	0.00372	CcSEcCtD
Acetylcysteine—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000156	0.00371	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000152	0.00362	CcSEcCtD
Acetylcysteine—IKBKB—Innate Immune System—CARD9—ankylosing spondylitis	0.000151	0.0026	CbGpPWpGaD
Acetylcysteine—Erythema—Methotrexate—ankylosing spondylitis	0.00015	0.00358	CcSEcCtD
Acetylcysteine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000149	0.00355	CcSEcCtD
Acetylcysteine—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000148	0.00354	CcSEcCtD
Acetylcysteine—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000148	0.00354	CcSEcCtD
Acetylcysteine—IKBKB—Regulation of toll-like receptor signaling pathway—TLR4—ankylosing spondylitis	0.000148	0.00255	CbGpPWpGaD
Acetylcysteine—Urticaria—Triamcinolone—ankylosing spondylitis	0.000148	0.00352	CcSEcCtD
Acetylcysteine—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000147	0.00351	CcSEcCtD
Acetylcysteine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000147	0.0035	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Prednisone—ankylosing spondylitis	0.000147	0.0035	CcSEcCtD
Acetylcysteine—Oedema—Prednisone—ankylosing spondylitis	0.000147	0.0035	CcSEcCtD
Acetylcysteine—IKBKB—Cardiac Hypertrophic Response—TNF—ankylosing spondylitis	0.000147	0.00253	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—IL1RN—ankylosing spondylitis	0.000146	0.00253	CbGpPWpGaD
Acetylcysteine—IKBKB—Toll-Like Receptors Cascades—TLR4—ankylosing spondylitis	0.000146	0.00252	CbGpPWpGaD
Acetylcysteine—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000146	0.00347	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000146	0.00347	CcSEcCtD
Acetylcysteine—Shock—Prednisone—ankylosing spondylitis	0.000145	0.00344	CcSEcCtD
Acetylcysteine—Tachycardia—Prednisone—ankylosing spondylitis	0.000143	0.00341	CcSEcCtD
Acetylcysteine—Skin disorder—Prednisone—ankylosing spondylitis	0.000143	0.0034	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000142	0.00338	CcSEcCtD
Acetylcysteine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000137	0.00326	CcSEcCtD
Acetylcysteine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000137	0.00326	CcSEcCtD
Acetylcysteine—Urticaria—Dexamethasone—ankylosing spondylitis	0.000134	0.00319	CcSEcCtD
Acetylcysteine—Urticaria—Betamethasone—ankylosing spondylitis	0.000134	0.00319	CcSEcCtD
Acetylcysteine—Dizziness—Prednisolone—ankylosing spondylitis	0.000134	0.00318	CcSEcCtD
Acetylcysteine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000133	0.00318	CcSEcCtD
Acetylcysteine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000133	0.00318	CcSEcCtD
Acetylcysteine—Pruritus—Triamcinolone—ankylosing spondylitis	0.000132	0.00313	CcSEcCtD
Acetylcysteine—Cough—Methotrexate—ankylosing spondylitis	0.000131	0.00313	CcSEcCtD
Acetylcysteine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000131	0.00313	CcSEcCtD
Acetylcysteine—GRIN1—Spinal Cord Injury—TNF—ankylosing spondylitis	0.00013	0.00224	CbGpPWpGaD
Acetylcysteine—Dyspepsia—Prednisone—ankylosing spondylitis	0.000129	0.00308	CcSEcCtD
Acetylcysteine—CHUK—Disease—ANTXR2—ankylosing spondylitis	0.000129	0.00222	CbGpPWpGaD
Acetylcysteine—Rash—Prednisolone—ankylosing spondylitis	0.000127	0.00304	CcSEcCtD
Acetylcysteine—Dermatitis—Prednisolone—ankylosing spondylitis	0.000127	0.00303	CcSEcCtD
Acetylcysteine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000127	0.00303	CcSEcCtD
Acetylcysteine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000123	0.00293	CcSEcCtD
Acetylcysteine—Anaphylactic shock—Methotrexate—ankylosing spondylitis	0.000123	0.00292	CcSEcCtD
Acetylcysteine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000123	0.00292	CcSEcCtD
Acetylcysteine—Nausea—Prednisolone—ankylosing spondylitis	0.00012	0.00286	CcSEcCtD
Acetylcysteine—Pruritus—Dexamethasone—ankylosing spondylitis	0.000119	0.00284	CcSEcCtD
Acetylcysteine—Pruritus—Betamethasone—ankylosing spondylitis	0.000119	0.00284	CcSEcCtD
Acetylcysteine—Skin disorder—Methotrexate—ankylosing spondylitis	0.000119	0.00284	CcSEcCtD
Acetylcysteine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000119	0.00283	CcSEcCtD
Acetylcysteine—Vomiting—Triamcinolone—ankylosing spondylitis	0.000118	0.00282	CcSEcCtD
Acetylcysteine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000118	0.00281	CcSEcCtD
Acetylcysteine—Rash—Triamcinolone—ankylosing spondylitis	0.000117	0.00279	CcSEcCtD
Acetylcysteine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000117	0.00279	CcSEcCtD
Acetylcysteine—Rash—Methylprednisolone—ankylosing spondylitis	0.000117	0.00279	CcSEcCtD
Acetylcysteine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000117	0.00278	CcSEcCtD
Acetylcysteine—Urticaria—Prednisone—ankylosing spondylitis	0.000117	0.00278	CcSEcCtD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—IL1A—ankylosing spondylitis	0.000116	0.002	CbGpPWpGaD
Acetylcysteine—Body temperature increased—Prednisone—ankylosing spondylitis	0.000116	0.00277	CcSEcCtD
Acetylcysteine—CHUK—MicroRNAs in cardiomyocyte hypertrophy—TNF—ankylosing spondylitis	0.000115	0.00199	CbGpPWpGaD
Acetylcysteine—CHUK—Apoptosis—TNF—ankylosing spondylitis	0.000115	0.00199	CbGpPWpGaD
Acetylcysteine—Hypotension—Methotrexate—ankylosing spondylitis	0.000115	0.00273	CcSEcCtD
Acetylcysteine—Dizziness—Dexamethasone—ankylosing spondylitis	0.000112	0.00266	CcSEcCtD
Acetylcysteine—Dizziness—Betamethasone—ankylosing spondylitis	0.000112	0.00266	CcSEcCtD
Acetylcysteine—CHUK—Immune System—IL1R2—ankylosing spondylitis	0.000112	0.00192	CbGpPWpGaD
Acetylcysteine—Nausea—Triamcinolone—ankylosing spondylitis	0.00011	0.00263	CcSEcCtD
Acetylcysteine—Nausea—Methylprednisolone—ankylosing spondylitis	0.00011	0.00262	CcSEcCtD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—HLA-B—ankylosing spondylitis	0.00011	0.0019	CbGpPWpGaD
Acetylcysteine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000109	0.00261	CcSEcCtD
Acetylcysteine—Somnolence—Methotrexate—ankylosing spondylitis	0.000109	0.0026	CcSEcCtD
Acetylcysteine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000108	0.00258	CcSEcCtD
Acetylcysteine—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000108	0.00257	CcSEcCtD
Acetylcysteine—Vomiting—Betamethasone—ankylosing spondylitis	0.000107	0.00255	CcSEcCtD
Acetylcysteine—Vomiting—Dexamethasone—ankylosing spondylitis	0.000107	0.00255	CcSEcCtD
Acetylcysteine—CHUK—TNF alpha Signaling Pathway—TNF—ankylosing spondylitis	0.000107	0.00185	CbGpPWpGaD
Acetylcysteine—Rash—Betamethasone—ankylosing spondylitis	0.000106	0.00253	CcSEcCtD
Acetylcysteine—Rash—Dexamethasone—ankylosing spondylitis	0.000106	0.00253	CcSEcCtD
Acetylcysteine—Dermatitis—Betamethasone—ankylosing spondylitis	0.000106	0.00253	CcSEcCtD
Acetylcysteine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000106	0.00253	CcSEcCtD
Acetylcysteine—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000106	0.00252	CcSEcCtD
Acetylcysteine—CHUK—Immune System—ERAP1—ankylosing spondylitis	0.000106	0.00182	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—IL1A—ankylosing spondylitis	0.000105	0.00182	CbGpPWpGaD
Acetylcysteine—IKBKB—Apoptosis—TNF—ankylosing spondylitis	0.000105	0.0018	CbGpPWpGaD
Acetylcysteine—IKBKB—MicroRNAs in cardiomyocyte hypertrophy—TNF—ankylosing spondylitis	0.000105	0.0018	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—HLA-C—ankylosing spondylitis	0.000104	0.0018	CbGpPWpGaD
Acetylcysteine—Pruritus—Prednisone—ankylosing spondylitis	0.000104	0.00248	CcSEcCtD
Acetylcysteine—GRIN1—SIDS Susceptibility Pathways—TNF—ankylosing spondylitis	0.000104	0.00179	CbGpPWpGaD
Acetylcysteine—CHUK—Cytokine Signaling in Immune system—HLA-A—ankylosing spondylitis	0.000102	0.00176	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL1R2—ankylosing spondylitis	0.000101	0.00174	CbGpPWpGaD
Acetylcysteine—Nausea—Dexamethasone—ankylosing spondylitis	0.0001	0.00239	CcSEcCtD
Acetylcysteine—Nausea—Betamethasone—ankylosing spondylitis	0.0001	0.00239	CcSEcCtD
Acetylcysteine—CHUK—Adaptive Immune System—HLA-C—ankylosing spondylitis	0.0001	0.00173	CbGpPWpGaD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—HLA-B—ankylosing spondylitis	9.97e-05	0.00172	CbGpPWpGaD
Acetylcysteine—CHUK—Toll-like Receptor Signaling Pathway—TNF—ankylosing spondylitis	9.87e-05	0.0017	CbGpPWpGaD
Acetylcysteine—Urticaria—Methotrexate—ankylosing spondylitis	9.75e-05	0.00232	CcSEcCtD
Acetylcysteine—IKBKB—TNF alpha Signaling Pathway—TNF—ankylosing spondylitis	9.72e-05	0.00168	CbGpPWpGaD
Acetylcysteine—Dizziness—Prednisone—ankylosing spondylitis	9.71e-05	0.00231	CcSEcCtD
Acetylcysteine—Body temperature increased—Methotrexate—ankylosing spondylitis	9.7e-05	0.00231	CcSEcCtD
Acetylcysteine—CHUK—Immune System—CARD9—ankylosing spondylitis	9.67e-05	0.00167	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—ERAP1—ankylosing spondylitis	9.59e-05	0.00165	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—HLA-C—ankylosing spondylitis	9.45e-05	0.00163	CbGpPWpGaD
Acetylcysteine—Vomiting—Prednisone—ankylosing spondylitis	9.34e-05	0.00222	CcSEcCtD
Acetylcysteine—Rash—Prednisone—ankylosing spondylitis	9.26e-05	0.00221	CcSEcCtD
Acetylcysteine—Dermatitis—Prednisone—ankylosing spondylitis	9.25e-05	0.0022	CcSEcCtD
Acetylcysteine—IKBKB—Cytokine Signaling in Immune system—HLA-A—ankylosing spondylitis	9.24e-05	0.00159	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—HLA-C—ankylosing spondylitis	9.08e-05	0.00157	CbGpPWpGaD
Acetylcysteine—Hypersensitivity—Methotrexate—ankylosing spondylitis	9.04e-05	0.00215	CcSEcCtD
Acetylcysteine—IKBKB—Toll-like Receptor Signaling Pathway—TNF—ankylosing spondylitis	8.95e-05	0.00154	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CARD9—ankylosing spondylitis	8.77e-05	0.00151	CbGpPWpGaD
Acetylcysteine—Nausea—Prednisone—ankylosing spondylitis	8.72e-05	0.00208	CcSEcCtD
Acetylcysteine—Pruritus—Methotrexate—ankylosing spondylitis	8.68e-05	0.00207	CcSEcCtD
Acetylcysteine—Dizziness—Methotrexate—ankylosing spondylitis	8.12e-05	0.00193	CcSEcCtD
Acetylcysteine—Vomiting—Methotrexate—ankylosing spondylitis	7.8e-05	0.00186	CcSEcCtD
Acetylcysteine—Rash—Methotrexate—ankylosing spondylitis	7.74e-05	0.00184	CcSEcCtD
Acetylcysteine—Dermatitis—Methotrexate—ankylosing spondylitis	7.73e-05	0.00184	CcSEcCtD
Acetylcysteine—CHUK—Regulation of toll-like receptor signaling pathway—TNF—ankylosing spondylitis	7.7e-05	0.00133	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—CD79A—ankylosing spondylitis	7.64e-05	0.00132	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—B3GNT2—ankylosing spondylitis	7.59e-05	0.00131	CbGpPWpGaD
Acetylcysteine—Nausea—Methotrexate—ankylosing spondylitis	7.29e-05	0.00174	CcSEcCtD
Acetylcysteine—IKBKB—Regulation of toll-like receptor signaling pathway—TNF—ankylosing spondylitis	6.99e-05	0.0012	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—CD79A—ankylosing spondylitis	6.92e-05	0.00119	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—CD40LG—ankylosing spondylitis	6.22e-05	0.00107	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—HLA-B—ankylosing spondylitis	6.17e-05	0.00106	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—HLA-C—ankylosing spondylitis	6.07e-05	0.00105	CbGpPWpGaD
Acetylcysteine—IKBKB—MAPK Signaling Pathway—TNF—ankylosing spondylitis	6e-05	0.00104	CbGpPWpGaD
Acetylcysteine—CHUK—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	5.97e-05	0.00103	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—HLA-B—ankylosing spondylitis	5.92e-05	0.00102	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—CD40LG—ankylosing spondylitis	5.64e-05	0.000973	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—HLA-B—ankylosing spondylitis	5.59e-05	0.000964	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—HLA-C—ankylosing spondylitis	5.51e-05	0.00095	CbGpPWpGaD
Acetylcysteine—CHUK—Adaptive Immune System—HLA-A—ankylosing spondylitis	5.49e-05	0.000946	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—CRP—ankylosing spondylitis	5.45e-05	0.00094	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—HLA-B—ankylosing spondylitis	5.37e-05	0.000926	CbGpPWpGaD
Acetylcysteine—SLCO1B1—Metabolism—B3GNT2—ankylosing spondylitis	5.33e-05	0.00092	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL1RN—ankylosing spondylitis	5.27e-05	0.00091	CbGpPWpGaD
Acetylcysteine—CHUK—Innate Immune System—TLR4—ankylosing spondylitis	5.22e-05	0.000901	CbGpPWpGaD
Acetylcysteine—IKBKB—Adaptive Immune System—HLA-A—ankylosing spondylitis	4.97e-05	0.000858	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—CRP—ankylosing spondylitis	4.94e-05	0.000852	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL1RN—ankylosing spondylitis	4.78e-05	0.000825	CbGpPWpGaD
Acetylcysteine—IKBKB—Innate Immune System—TLR4—ankylosing spondylitis	4.74e-05	0.000817	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CD79A—ankylosing spondylitis	4.63e-05	0.000799	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CD79A—ankylosing spondylitis	4.2e-05	0.000724	CbGpPWpGaD
Acetylcysteine—GRIN1—Developmental Biology—TNF—ankylosing spondylitis	4.13e-05	0.000712	CbGpPWpGaD
Acetylcysteine—GRIN2B—Developmental Biology—TNF—ankylosing spondylitis	4.03e-05	0.000694	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—IL1A—ankylosing spondylitis	3.8e-05	0.000655	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CD40LG—ankylosing spondylitis	3.78e-05	0.000651	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—PTGER4—ankylosing spondylitis	3.65e-05	0.000629	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—HLA-B—ankylosing spondylitis	3.59e-05	0.000619	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—IL1A—ankylosing spondylitis	3.44e-05	0.000594	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CD40LG—ankylosing spondylitis	3.42e-05	0.00059	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—HLA-A—ankylosing spondylitis	3.33e-05	0.000574	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—PTGER4—ankylosing spondylitis	3.31e-05	0.00057	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—HLA-B—ankylosing spondylitis	3.26e-05	0.000562	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—CRP—ankylosing spondylitis	3.17e-05	0.000547	CbGpPWpGaD
Acetylcysteine—CHUK—Disease—HLA-A—ankylosing spondylitis	3.07e-05	0.00053	CbGpPWpGaD
Acetylcysteine—CHUK—Immune System—TLR4—ankylosing spondylitis	3.04e-05	0.000525	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—HLA-A—ankylosing spondylitis	3.02e-05	0.00052	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—CRP—ankylosing spondylitis	2.88e-05	0.000496	CbGpPWpGaD
Acetylcysteine—IKBKB—Immune System—TLR4—ankylosing spondylitis	2.76e-05	0.000476	CbGpPWpGaD
Acetylcysteine—CHUK—Signaling Pathways—MMP3—ankylosing spondylitis	2.6e-05	0.000448	CbGpPWpGaD
Acetylcysteine—IKBKB—Signaling Pathways—MMP3—ankylosing spondylitis	2.35e-05	0.000406	CbGpPWpGaD
